Atrial Flutter Dan Atrial Fibrilasi: Hauda El Rasyid
Atrial Flutter Dan Atrial Fibrilasi: Hauda El Rasyid
Atrial Flutter Dan Atrial Fibrilasi: Hauda El Rasyid
Hauda el rasyid
Divisi aritmia
Bagian kardiologi dan kedokteran vaskular
FK UNAND/RSUP DR. M. Djamil Padang
1
Mekanisme aritmia
2
Supra ventricular arrhitmia
Supra Ventricular Tachycardia /SVT :
AT : atrial tachycardia
JT : junctional tachycardia
Atrial flutter /AFL
21
therapy
• Acute :
unstable haemodynamic
synhronise cardioversion
informed concern
sedation
23
RF Ablation of Atrial Flutter
26
27
28
Clinical Events (Outcomes) Affected by AF
Camm AJ, et al. Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial
Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31(19):2369–2429
30
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: 31
Executive Summary JACC VOL. 64, NO. 21, 2014
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation:
Executive Summary JACC VOL. 64, NO. 21, 2014
32
33
34
35
36
37
Who should be referred?
• Symptomatic patients
– AVNRT (>90% succes rates)
– WPW and symptomatic AVRT (CCB ; BB and Dig not
appropriate as sole therapy) (>90%)
– Aflutter(>90%)
– AFib (40-70%)
• High risk for sudden death
– AFib with WPW and cycle length <250 ms
• Not amenable to catheter ablation
– MAT
– Reversible causes (thryotoxicosis; PE; post-op)
39
SVT AVNRT
DIAGNOSIS
• SYMPTOMS
• ECG, HOLTER,ILR
40
SVT AVNRT
41
42
43
44